Affichem in the final of European Health Catapult 2017 competition

Affichem in the final of European Health Catapult 2017 competition

AFFITAN project gets a Seal of Excellence from European Commission

AFFITAN project gets a Seal of Excellence from European Commission

Science publication

Science publication

Cholesterol metabolites can promote or suppress breast cancer.
Nature Communications publication

Nature Communications publication

The joint research between Affichem and the INSERM UMR1037 team co-led by Dr. Marc & Sandrine Poirot has led to the characterization of the Dendrogenin A as the first steroidal alkaloid identified in humans.
NCE - Biomarker - Drug design - Anticancer therapy - Cell differentiation - Receptor - Enzyme - Metabolism - Cancer - Deafness - Deafness - Melanoma - Neurodegenerative disease - Medicinal chemistry - Biotechnology - First in class molecule - New Chemical Entities - Cholesterol - Tamoxifen - Immunotherapy - Exosome - Oncology - Dendritic cell - Theranostic - Diagnosis - Prognosis -